Current:Home > ScamsEli Lilly says an experimental drug slows Alzheimer's worsening -CapitalWay
Eli Lilly says an experimental drug slows Alzheimer's worsening
View
Date:2025-04-11 19:19:37
WASHINGTON — Eli Lilly and Co. said Wednesday its experimental Alzheimer's drug appeared to slow worsening of the mind-robbing disease in a large study.
In the 18-month trial, people in the early stages of Alzheimer's who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug, Lilly announced in a press release.
The drug is designed to target and clear away a sticky protein called beta-amyloid that builds up into brain-clogging plaques that are one hallmark of Alzheimer's.
A similar amyloid-targeting drug, Eisai and Biogen's Leqembi, recently hit the market with similar evidence that it could modestly slow Alzheimer's — and also some safety concerns, brain swelling or small brain bleeds.
Donanemab also comes with that risk. Lilly said in its study, the brain side effects caused the deaths of two participants and a third also died after a serious case.
The preliminary study results haven't been vetted by outside experts. Indianapolis-based Lilly plans to release more details at an international Alzheimer's meeting this summer and is seeking Food and Drug Administration approval of the drug.
veryGood! (83684)
Related
- Nevada attorney general revives 2020 fake electors case
- Charles Silverstein, a psychologist who helped destigmatize homosexuality, dies at 87
- Does drinking alcohol affect your dementia risk? We asked a researcher for insights
- Actor Bruce Willis has frontotemporal dementia. Here's what to know about the disease
- B.A. Parker is learning the banjo
- Fossil Fuels (Not Wildfires) Biggest Source of a Key Arctic Climate Pollutant, Study Finds
- The glam makeovers of Pakistan's tractors show how much farmers cherish them
- Benzene Emissions on the Perimeters of Ten Refineries Exceed EPA Limits
- Federal hiring is about to get the Trump treatment
- One state looks to get kids in crisis out of the ER — and back home
Ranking
- Skins Game to make return to Thanksgiving week with a modern look
- Prosecution, defense rest in Pittsburgh synagogue shooting trial
- Democrats control Michigan for the first time in 40 years. They want gun control
- California child prodigy on his SpaceX job: The work I'm going to be doing is so cool
- Newly elected West Virginia lawmaker arrested and accused of making terroristic threats
- A food subsidy many college students relied on is ending with the pandemic emergency
- Coastal Flooding Is Erasing Billions in Property Value as Sea Level Rises. That’s Bad News for Cities.
- NYC Mayor Eric Adams Calls Out Reckless and Irresponsible Paparazzi After Harry and Meghan Incident
Recommendation
Chuck Scarborough signs off: Hoda Kotb, Al Roker tribute legendary New York anchor
Trump Makes Nary a Mention of ‘Climate Change,’ Touting America’s Fossil Fuel Future
5 Reasons Many See Trump’s Free Trade Deal as a Triumph for Fossil Fuels
Which 2024 Republican candidates would pardon Trump if they won the presidency? Here's what they're saying.
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
10 things to know about how social media affects teens' brains
Arctic Bogs Hold Another Global Warming Risk That Could Spiral Out of Control
Why The Challenge: World Championship Winner Is Taking a Break From the Game